Relive the excitement of the Patriots’ path to their fourth Super Bowl Championship with “Pumped”, a special commemorative book from The Boston Globe. Order now.

Around the Region

Cubist drug gets expanded OK

Continue reading below

Cubist Pharmaceuticals Inc. said that the Food and Drug Administration has approved expanded use for Entereg, a drug used after gastrointestinal surgery.

Entereg is designed to accelerate healing following certain surgeries, Lexington-based Cubist said. Entereg was approved in the United States in 2008.

“Delayed GI (gastrointestinal) recovery is one of the most common causes of prolonged hospital stays in patients undergoing major abdominopelvic surgery,” Cubist chief scientific officer Steven Gilman said in a statement. “We are pleased that doctors will have the option to help speed GI recovery for appropriate patients who have undergone surgeries that included a bowel resection.”

Chris Reidy can be reached at reidy@globe.com.
Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com